Feb 29, 2024 / 06:00PM GMT
Francesca M. DeMartino - Pfizer Inc. - Chief IR Officer
Welcome, everyone. Good afternoon, and thank you so much for joining us today, both here at our New York headquarters and online. I'm Francesca DeMartino, Chief Investor Relations Officer for Pfizer, and it is my great honor to kick off a day we've all been waiting for, our Oncology Innovation Day.
Before we get started, I want to remind you that today, we will be making forward-looking statements in discussing certain non-GAAP financial measures. I encourage you to read the disclaimers in our slide presentation, which are also shown on the screen in the room. In addition, the full transcript and video recording of today's event will be posted on the Pfizer IR website, once available, approximately 48 hours post event.
One final note for those in the room, you should have received your unique WiFi access information when you picked up your badge. Please see a member of the IR team with any questions.
We have a robust agenda today, which we've developed to provide you with a comprehensive overview of our new Pfizer Oncology
Pfizer Inc To Host Oncology Innovation Day Transcript
Mar 01, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers